Abstract
Introduction/Aims The primary aim of this study is to define the sonographic diaphragm phenotype of Long COVID patients with non-specific dyspnea and fatigue. We analyzed patients referred from a pulmonary medicine COVID clinic without any intrinsic cardiopulmonary explanation for their new symptoms. Additionally, we report the functional outcomes of patients who completed an outpatient cardiopulmonary physical therapy program.
Methods This was a retrospective cohort study (n = 37) of consecutive patients referred for neuromuscular assessment centered on B-mode ultrasound of the diaphragm muscle. Patients were recruited from a single academic hospital between February 25, 2021 and October 7, 2021.
Results Sonographic abnormalities were identified in 65% (24/37) of patients, and in the vast majority of cases (23/24) was defined by low diaphragm muscle thickness. Thinner diaphragm muscles positively correlated with lower serum creatinine and creatine kinase values, but there was no association with markers of systemic inflammation. Eighteen patients participated in outpatient cardiopulmonary physical therapy that included respiratory muscle training, and 77.8% (n=14) had documented improvement.
Discussion In the outpatient rehabilitation setting, patients with Long COVID frequently display low diaphragm muscle thickness, but intact muscle contractility on sonographic studies. We speculate this represents a form of disuse atrophy, which has a good response rate to cardiopulmonary physical therapy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Belle Carnell Regenerative Neurorehabilitation fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Northwestern University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations:
-Ethics approval and consent to participate: yes
-Consent for publication: not applicable
-Availability of data and materials: will be made available on request
-Competing interests: none
-Funding: no funding
None of the authors has any conflict of interest to disclose
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
